It is not suitable for everyone, results vary considerably between individuals, and it works alongside dietary change and activity rather than instead of them
Regular monitoring and follow-up appointments are needed to reassess your dose and progress
Risk Factors of Ipamorelin and CJC-1295 Risk Factors of Ipamorelin A risk factor is increased insulin secretion
Patients taking Wegovy should consider drinking less, particularly during dose escalation, and always consume alcohol with food whilst monitoring individual tolerance
GLP-1 medications are not licensed specifically for ED, but by supporting weight loss and improving overall metabolic health, they can help reduce many of the underlying risk factors
By targeting different pathways involved in appetite regulation and metabolism, these medications can address multiple aspects of obesity and diabetes simultaneously